TipRanks
Orphazyme (OZYMF)
OTHER OTC:OZYMF
US Market

Orphazyme (OZYMF) Income Statement

12 Followers

Orphazyme Income Statement

Last quarter (Q2 2026), Orphazyme's total revenue was kr100.00K, an increase of Infinity% from the same quarter last year. In Q2, Orphazyme's net income was kr1.02M. See Orphazyme’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 309.00Kkr 0.00kr 0.00kr 0.00kr 36.19M
Gross Profit
kr 309.00Kkr 0.00kr 0.00kr -782.00Kkr 18.08M
Operating Expenses
kr 2.75Mkr 201.00Kkr 27.04Mkr 40.46Mkr 83.47M
Depreciation and Amortization
kr 0.00kr 0.00kr 782.00Kkr 782.00Kkr 18.11M
EBITDA
kr -2.45Mkr -201.00Kkr -12.10Mkr -40.46Mkr -603.91M
Operating Income
kr -2.45Mkr -201.00Kkr -27.04Mkr -41.24Mkr -83.47M
Other Income/Expenses
kr 1.59Mkr -97.00Kkr 993.00Kkr 185.00Kkr 36.00K
Pretax Income
kr -859.00Kkr -298.00Kkr -26.05Mkr -41.06Mkr -83.44M
Net Income
kr -859.00Kkr -298.00Kkr -26.05Mkr -110.59Mkr -626.54M
Per Share Metrics
Basic EPS
kr -21.00kr -8.00kr -0.74kr -3.14kr -17.94
Diluted EPS
kr -21.00kr -8.00kr -0.74kr -3.14kr -17.94
Weighted Average Shares Outstanding
41.71K 37.13K 35.00K 35.27K 34.92K
Weighted Average Shares Outstanding (Diluted)
41.71K 37.13K 35.00K 35.27K 34.92K
Currency in DKK

Orphazyme Earnings and Revenue History